Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.62
+0.29 (5.44%)
At close: Mar 9, 2026, 4:00 PM EDT
5.61
-0.01 (-0.18%)
After-hours: Mar 9, 2026, 7:56 PM EDT

Immuneering Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2019
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2019
Market Capitalization
36342568215128426
Upgrade
Market Cap Growth
583.44%521.96%-68.25%67.99%-69.91%-
Upgrade
Enterprise Value
1942012212216267
Upgrade
Last Close Price
5.626.582.207.354.8516.17
Upgrade
PS Ratio
----404.05204.62
Upgrade
PB Ratio
1.661.951.652.381.172.73
Upgrade
P/TBV Ratio
1.722.011.992.581.252.86
Upgrade
EV/Sales Ratio
----49.59128.17
Upgrade
Debt / Equity Ratio
0.020.020.100.050.040.03
Upgrade
Net Debt / Equity Ratio
-0.77-0.77-0.77-0.90-0.92-0.93
Upgrade
Net Debt / EBITDA Ratio
2.862.860.501.401.964.28
Upgrade
Net Debt / FCF Ratio
3.723.720.581.652.254.68
Upgrade
Asset Turnover
----0.000.02
Upgrade
Quick Ratio
17.1617.164.8210.9213.1026.53
Upgrade
Current Ratio
17.5017.505.2811.3613.5027.04
Upgrade
Return on Equity (ROE)
-43.12%-43.12%-92.51%-53.36%-38.00%-35.00%
Upgrade
Return on Assets (ROA)
-26.07%-26.07%-51.57%-32.46%-22.38%-20.65%
Upgrade
Return on Capital Employed (ROCE)
-26.80%-26.80%-141.70%-61.70%-45.30%-21.00%
Upgrade
Earnings Yield
-15.44%-13.19%-89.35%-24.86%-39.44%-7.88%
Upgrade
FCF Yield
-12.53%-10.71%-80.64%-22.92%-35.02%-7.26%
Upgrade
Buyback Yield / Dilution
-46.80%-46.80%-5.51%-7.69%-93.84%-175.00%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.